Compounds > sch 34826
Page last updated: 2024-09-03

sch 34826 and enkephalinamide-met, ala(2)-

sch 34826 has been researched along with enkephalinamide-met, ala(2)- in 1 studies

Compound Research Comparison

Studies
(sch 34826)		Trials
(sch 34826)		Recent Studies (post-2010)
(sch 34826)		Studies
(enkephalinamide-met, ala(2)-)		Trials
(enkephalinamide-met, ala(2)-)		Recent Studies (post-2010) (enkephalinamide-met, ala(2)-)
312036414

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnett, A; Berger, JG; Billard, W; Chapman, R; Chipkin, RE; Iorio, LC1

Other Studies

1 other study(ies) available for sch 34826 and enkephalinamide-met, ala(2)-

ArticleYear
Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 245, Issue:3

    Topics: Administration, Oral; Analgesics; Animals; Dioxolanes; Dioxoles; Dipeptides; Drug Synergism; Enkephalin, Methionine; Gastrointestinal Motility; Male; Metalloendopeptidases; Mice; Naloxone; Neprilysin; Rats; Respiration

1988